ALBIREO PHARMA INC (ALBO)
US01345P1066 - Common Stock
| MRQ (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 222.48M | 248.11M | 251.30M | 131.80M | 163.90M | |||
| Receivables | 2.03M | 3.27M | N/A | N/A | 2.90M | |||
| Inventories | 3.15M | 194.00K | N/A | N/A | N/A | |||
| Other Current Assets | 11.18M | 17.36M | 10.60M | 10.00M | 900.00K | |||
| Total Current Assets | 238.84M | 268.93M | 261.90M | 141.80M | 167.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.30M | 12.67M | 4.60M | 5.30M | 200.00K | |||
| Goodwill | 17.26M | 17.26M | 17.30M | 17.30M | 17.30M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 63.82M | 3.19M | 1.90M | 700.00K | 400.00K | |||
| Total Non-Current Assets | 82.39M | 33.12M | 23.70M | 23.30M | 17.80M | |||
| TOTAL ASSETS | 321.22M | 302.05M | 285.60M | 165.10M | 185.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 25.36M | 37.35M | 19.70M | 14.00M | 8.20M | |||
| Accounts Payable | 6.95M | 6.52M | 5.30M | 4.80M | 4.40M | |||
| Other Current Liabilities | 5.50M | 1.48M | 300.00K | 100.00K | 300.00K | |||
| Total Current Liabilities | 37.82M | 45.35M | 25.30M | 18.90M | 12.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 10.00M | 9.60M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 183.33M | 71.09M | 69.50M | 53.00M | 50.00M | |||
| Total Non-Current Liabilities | 183.33M | 81.10M | 79.10M | 53.00M | 50.00M | |||
| TOTAL LIABILITIES | 221.15M | 126.44M | 104.40M | 71.90M | 62.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -421.03M | -300.85M | -266.80M | -159.20M | -96.50M | |||
| Additional Paid In Capital | 512.91M | 475.39M | 456.50M | 245.80M | 214.70M | |||
| Common Shares | 207.00K | 193.00K | 200.00K | 100.00K | 100.00K | |||
| Treasury Stock | -230.00K | -230.00K | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 8.21M | 1.10M | -8.60M | 6.50M | 4.30M | |||
| Shares Outstanding | 20.69M | 19.30M | 19.10M | 12.70M | 12.00M | |||
| Tangible Book Value per Share | 4.00 | 8.21 | 8.58 | 5.98 | 8.78 | |||
| Total Shareholders' Equity | 100.07M | 175.61M | 181.20M | 93.20M | 122.60M | |||
| TOTAL LIABILITIES AND EQUITY | 321.22M | 302.05M | 285.60M | 165.10M | 185.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.06 | 0.05 | N/A | N/A | |||
| Current Ratio | 6.32 | 5.93 | 10.35 | 7.50 | 13.10 | |||
| Return On Assets (ROA) | -40.83% | -11.27% | -37.69% | -37.99% | -24.86% | |||
| Return On Equity (ROE) | -131.05% | -19.38% | -59.40% | -67.30% | -37.61% | |||
All data in USD